市場調査レポート

ヒアルロン酸製品市場(単回投与、3回投与サイクル、5回投与サイクル) - 世界の業界分析、市場規模、シェア、成長、動向および予測

Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 301492
出版日 ページ情報 英文 106 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
ヒアルロン酸製品市場(単回投与、3回投与サイクル、5回投与サイクル) - 世界の業界分析、市場規模、シェア、成長、動向および予測 Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2014年04月30日 ページ情報: 英文 106 Pages
概要

ヒアルロン酸は、体に栄養を送り体内組織の水分保持を促進するグリコサミノグリカンという物質で、関節や免疫系などに存在しています。ヒアルロン酸は関節軟骨の重要な要素として軟骨細胞の周りをコーティングしています。

当レポートでは、世界のヒアルロン酸製品市場について調査し、市場の概要と2013〜2019年の予測、地域別動向、参入企業のプロファイルをまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクションと市場の定義
  • 市場動向
    • 促進因子
    • 阻害因子
    • 市場の機会
  • ポーターズファイブフォース分析
  • 市場の魅力度分析
  • 主要企業別市場シェア分析

第4章 製品別市場

  • 概要
  • 単回投与サイクル製品
  • 3回投与サイクル製品
  • 5回投与サイクル製品

第5章 用途別市場

  • 概要
  • 変形性関節炎
  • 眼科
  • 皮膚フィラー
  • 膀胱尿管逆流

第6章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 提言

第8章 企業プロファイル

  • Alcon, Inc.
  • Allergan, Inc.
  • Anika Therapeutics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ferring Pharmaceuticals, Inc.
  • Fidia Farmaceutici SpA
  • GALDERMA S.A.
  • Hyaltech Ltd.
  • LifeCore Biomedical LLC,
  • Meiji Seikaファルマ株式会社
  • Merz Aesthetics, Inc.
  • Sanofi
  • Salix Pharmaceuticals, Inc.
  • Seikagaku Corporation
  • Shanghai Jingfeng Pharmaceutical Co., Ltd.
  • Smith & Nephew plc
  • TRB CHEMEDICA INTERNATIONAL SA
  • Zimmer Holdings, Inc.

図表

目次

Hyaluronic acid (HA) is a glycosaminoglycan that helps in transportation of nutrients through the body and facilitate water retention in body tissue. It is naturally found in body - in joints, eye cavity, immune system and others. HA was observed to be an important component of articular cartilage where it is present in the form of a coat around each chondrocyte. This report studies the global hyaluronic acid products market by types of products, applications and the major geographic markets. Products market is segmented as single-injection, three-injection cycle and five-injection cycle. Similarly, applications market is segmented as osteoarthritis, ophthalmic surgery, dermal fillers and vesicoureteral reflux (VUR).

Geographically, the hyaluronic acid products market report segments the global market into four main regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market sizes and forecasts for the period 2011 to 2019 in terms of revenue (USD million), considering 2012 as the base year, have been provided for each technology type, application type and geographic region, along with their sub-segments (if any). The hyaluronic acid products market report also provides the compounded annual growth rate (CAGR %) during the forecast period 2013 to 2019 for all the aforementioned segments.

The market overview section of the hyaluronic acid products market report discusses the market dynamics with respect to market drivers, restraints and opportunities. This section also covers market attractiveness analysis (by geography) and Porter's five forces analysis for the global hyaluronic acid products market. Market share (%) for the major players operating in this market has also been provided for the year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares. The report concludes with the company profiles of key players operating in various segments of the market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the hyaluronic acid products market that have been profiled in this report include Allegran Inc., Anika Therapeutics, Inc., Merz Aesthetics, Inc., Sanofi (Genzyme) and Seikagaku.

The global hyaluronic acid products market is segmented as follows:

Hyaluronic Acid Products Market, by Products

  • Single-injection
  • Three-injection cycle
  • Five-injection cycle

Hyaluronic Acid Products Market, by Applications

  • Osteoarthritis
  • Ophthalmic
  • Dermal Fillers
  • Vesicoureteral Reflux (VUR)

Hyaluronic Acid Products Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
    • 1.3.2 Assumptions and Stipulations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
    • 2.1.1 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
  • 2.2 Comparative Analysis: Global Hyaluronic Acid Products Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview

  • 3.1 Introduction and Market Definition
  • 3.2 Market Dynamics
    • 3.2.1 Drivers
    • 3.2.2 Restraints
    • 3.2.3 Market Opportunities
  • 3.3 Porter's Five Forces Analysis: Global Hyaluronic Acid Products Market
    • 3.3.1 Bargaining power of suppliers
    • 3.3.2 Bargaining power of buyers
    • 3.3.3 Threat of Substitutes
    • 3.3.4 Threat of New Entrants
    • 3.3.5 Competitive Rivalry
  • 3.4 Market Attractiveness Analysis
    • 3.4.1 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
  • 3.5 Global Market Share Analysis for the Hyaluronic Acid Products, by Key Players, 2012 (Value %)
    • 3.5.1 Global Market Share by Key Players, 2012 (Value %)

Chapter 4 Global Hyaluronic Acid Products Market, by Products

  • 4.1 Overview
    • 4.1.1 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 - 2019 (USD Million)
  • 4.2 Single-Injection Cycle Products
    • 4.2.1 Global Single-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)
  • 4.3 Three-Injection Cycle Products
    • 4.3.1 Global Three-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)
  • 4.4 Five-Injection Cycle Products
    • 4.4.1 Global Five-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Hyaluronic Acid Products Market, by Applications

  • 5.1 Overview
    • 5.1.1 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • 5.2 Osteoarthritis
    • 5.2.1 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 - 2019 (USD Million)
  • 5.3 Ophthalmic
    • 5.3.1 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 - 2019 (USD Million)
  • 5.4 Dermal Fillers
    • 5.4.1 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 - 2019 (USD Million)
  • 5.5 Vesicoureteral Reflux (VUR)
    • 5.5.1 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 - 2019 (USD Million)

Chapter 6 Global Hyaluronic Acid Products Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2 North America
    • 6.2.1 North America Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • 6.4 Asia-Pacific
    • 6.4.1 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 RoW Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Recommendations

  • 7.1 Market Strategy for Success
    • 7.1.1 Focus on improving technology in order to increase the accuracy and reduce side-effects
    • 7.1.2 Multinational companies established partnership with the local professional/organization to expand their business
  • 7.2 Barriers to be considered
    • 7.2.1 High cost is a barrier for sufficient market expansion

Chapter 8 Company Profiles

  • 8.1 Alcon, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Allergan, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 Anika Therapeutics, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 F. Hoffmann-La Roche Ltd.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
    • 8.4.5 Recent Developments
  • 8.5 Ferring Pharmaceuticals, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 Fidia Farmaceutici SpA
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent developments
  • 8.7 GALDERMA S.A.
    • 8.7.1 Company Profile
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.5 Recent Developments
  • 8.8 Hyaltech Ltd.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Overview
    • 8.8.3 Product Portfolio
    • 8.8.4 Business Strategies
    • 8.8.5 Recent Developments
  • 8.9 LifeCore Biomedical LLC,
    • 8.9.1 Company Overview
    • 8.9.2 Financial Overview
    • 8.9.3 Product Portfolio
    • 8.9.4 Business Strategies
    • 8.9.5 Recent Developments
  • 8.10 Meiji Seika Pharma Co., Ltd.
    • 8.10.1 Company Profile
    • 8.10.2 Financial Overview
    • 8.10.3 Product Portfolio
    • 8.10.4 Business Strategies
    • 8.10.5 Recent Developments
  • 8.11 Merz Aesthetics, Inc.
    • 8.11.1 Company Overview
    • 8.11.2 Financial Overview
    • 8.11.3 Product Portfolio
    • 8.11.4 Business Strategies
    • 8.11.5 Recent Developments
  • 8.12 Sanofi
    • 8.12.1 Company Overview
    • 8.12.2 Financial Overview
    • 8.12.3 Product Portfolio
    • 8.12.4 Business Strategies
    • 8.12.5 Recent Developments
  • 8.13 Salix Pharmaceuticals, Inc.
    • 8.13.1 Company Overview
    • 8.13.2 Financial Overview
    • 8.13.3 Product Portfolio
    • 8.13.4 Business Strategies
    • 8.13.5 Recent Developments
  • 8.14 Seikagaku Corporation
    • 8.14.1 Company Overview
    • 8.14.2 Financial Overview
    • 8.14.3 Product Portfolio
    • 8.14.4 Business Strategies
    • 8.14.5 Recent Developments
  • 8.15 Shanghai Jingfeng Pharmaceutical Co., Ltd.
    • 8.15.1 Company Overview
    • 8.15.2 Financial Overview
    • 8.15.3 Product Portfolio
    • 8.15.4 Business Strategies
    • 8.15.5 Recent Developments
  • 8.16 Smith & Nephew plc
    • 8.16.1 Company Overview
    • 8.16.2 Financial Overview
    • 8.16.3 Product Portfolio
    • 8.16.4 Business Strategies
    • 8.16.5 Recent Development
  • 8.17 TRB CHEMEDICA INTERNATIONAL SA
    • 8.17.1 Company Overview
    • 8.17.2 Financial Overview
    • 8.17.3 Product Portfolio
    • 8.17.4 Business Strategies
    • 8.17.5 Recent Developments
  • 8.18 Zimmer Holdings, Inc.
    • 8.18.1 Business Overview
    • 8.18.2 Financial Overview
    • 8.18.3 Product Portfolio
    • 8.18.4 Business Strategies
    • 8.18.5 Recent Developments

List of Figures

  • FIG. 1 Hyaluronic Acid Products: Market Segmentation
  • FIG. 2 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
  • FIG. 3 Comparative Analysis: Global Hyaluronic Acid Products Market, by Geography, 2012 and 2019 (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Hyaluronic Acid Products Market
  • FIG. 5 Production Methods of Hyaluronic acid
  • FIG. 6 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
  • FIG. 7 Market Share Analysis: Hyaluronic Acid Products Market, 2012 (Value %)
  • FIG. 8 Comparative Analysis: Types of Hyaluronic Acid Products
  • FIG. 9 Global Single-Injection Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10 Global Three-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11 Global Five-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 - 2019 (USD Million)
  • FIG. 13 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 - 2019 (USD Million)
  • FIG. 14 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 - 2019 (USD Million)
  • FIG. 15 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 - 2019 (USD Million)
  • FIG. 16 North America Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17 Europe Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19 RoW Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20 Alcon, Inc., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 21 Allergan, Inc., Annual Sales Revenue: 2010 - 2012 (USD Million)
  • FIG. 22 Anika Therapeutics, Inc., Annual Revenue: 2010- 2012 (USD Million)
  • FIG. 23 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 24 Galderma S.A., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 25 Lifecore Biomedical LLC., Annual Revenue: 2010- 2012 (USD Million)
  • FIG. 26 Meiji Seika Pharma Co., Ltd., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 27 Merz Aesthetics Inc., Annual revenue: 2010 - 2012 (USD Million)
  • FIG. 28 Sanofi, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 29 Salix Pharmaceuticals, Inc., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 30 Seikagaku Corporation, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 31 Smith & Nephew PLC, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 32 Zimmer Holdings. Inc., Annual Revenue: 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
  • TABLE 2 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 -2019 (USD Million)
  • TABLE 3 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 -2019 (USD Million)
  • TABLE 4 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 -2019 (USD Million)
Back to Top